Picture of PAION AG logo

PA8 — PAION AG News Story

0.000.00%
de flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Brief: Paion Q1 Net Loss At EUR 3.2 Mln

May 8 (Reuters) - PAION AG  PA8G.DE :
    * PUBLISHES GROUP QUARTERLY STATEMENT FOR THE FIRST QUARTER
OF
2019
    * CASH AND CASH EQUIVALENTS OF EUR 15.6 MILLION AS OF 31
MARCH
2019
    * U.S. MARKET APPROVAL AND SUBSEQUENT LAUNCH OF REMIMAZOLAM
CAN BE
EXPECTED IN 2020
    * IN Q1 OF 2019, NO REVENUES WERE REALIZED
    * RESEARCH AND DEVELOPMENT EXPENSES AMOUNTED TO KEUR 3,063
IN Q1
OF 2019 (PRIOR-YEAR PERIOD: KEUR 3,360)
    * NET LOSS FOR Q1 OF 2019 AMOUNTED TO KEUR 3,241 (NET LOSS
IN
PRIOR-YEAR PERIOD: KEUR 3,125).
    * CONFIRMS ITS OUTLOOK FOR CURRENT FISCAL YEAR GIVEN IN
MARCH 2019

Source text for Eikon:  ID:nEQ1yHqWMa 
Further company coverage:  PA8G.DE 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on PAION AG

See all news